Order Article Reprints

Messore A, Malune P, Patacchini E, Madia VN, Ialongo D, Arpacioglu M, Albano A, Ruggieri G, Saccoliti F, Scipione L, et al. New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors. Pharmaceuticals. 2024; 17(5):650. https://doi.org/10.3390/ph17050650

Messore, Antonella, Paolo Malune, Elisa Patacchini, Valentina Noemi Madia, Davide Ialongo, Merve Arpacioglu, Aurora Albano, Giuseppe Ruggieri, Francesco Saccoliti, Luigi Scipione, and et al. 2024. "New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors" Pharmaceuticals 17, no. 5: 650. https://doi.org/10.3390/ph17050650

Messore, A., Malune, P., Patacchini, E., Madia, V. N., Ialongo, D., Arpacioglu, M., Albano, A., Ruggieri, G., Saccoliti, F., Scipione, L., Tramontano, E., Canton, S., Corona, A., Scognamiglio, S., Paulis, A., Suleiman, M., Al-Maqtari, H. M., Abid, F. M. A., Kawsar, S. M. A., ... Costi, R. (2024). New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors. Pharmaceuticals, 17(5), 650. https://doi.org/10.3390/ph17050650